Ledger.

Australian venture funding, tracked

Every round, fund close and exit we can source, with the article it was reported in and what it actually said.

4428
Rounds
2692
Startups
4549
Investors
Key

Person Invested in this round Raised it Closed a fund Mentioned

Amount confirmed Amount is an estimate

Mon 27 Nov 2023 4 entries
Fri 24 Nov 2023 1 entry
Thu 23 Nov 2023 5 entries
Wed 22 Nov 2023 7 entries
2 deals

Manufacturing news briefs — stories you might have missed

Manufacturing briefs: Victoria backs a skills program, Titomic supplies an Air France subsidiary, a pool-technology firm hires a sales chief, Bod Science banks a tax rebate, and Amaero completes a placement.

Tue 21 Nov 2023 1 entry
Mon 20 Nov 2023 3 entries
Fri 17 Nov 2023 4 entries
2 deals

University of Melbourne mental health startup using psychedelics kicks off with $4.5 million

Melbourne university funds backed a psychedelic medicines startup; six campus startups were showcased, and Tanarra Capital reported $100 million committed toward its alumni founders fund target.

Key hire

Manufacturing news briefs — stories you might have missed

Briefs roundup: Main Sequence adds Alison Deans as venture partner; Starpharma hands the CEO role to Cheryl Maley; DroneShield lands a $2.2 million repeat order; Q-CTRL will deliver quantum training with QUIN.

7 deals

Six Aussie startups that raised $21.3 million this week

Roundup of the week's Australian raises: Sitemate, Kashcade, Psychae Therapeutics, MediCann Health, Refilled and Upworth together banked $21.3 million across software, lending, psychedelic medicine, cannabis and drink dispensing.

Also Startup Daily·Startup Daily·SmartCompany·Forbes Australia

Thu 16 Nov 2023 9 entries
3 deals

Process digitisation proptech Sitemate nabs another $7.5 million in pre-Series A

Construction software startup Sitemate has secured $7.5 million in pre-Series A funding, led by Marbruck Investments with Blackbird and Artesian participating, and intends to double headcount during 2024.

Also SmartCompany·Startup Daily

News

Certa Therapeutics presents positive data from a Phase 2 clinical study highlighting the potential benefit of FT011 as a novel treatment for scleroderma

Melbourne biotech Certa Therapeutics reported encouraging Phase 2 results for its scleroderma drug FT011 at a US rheumatology meeting, with safety confirmed and a pivotal trial planned.

News

Certa Therapeutics presents positive data from a Phase 2 clinical study highlighting the potential benefit of FT011 as a novel treatment for scleroderma

Australian biotech Certa Therapeutics reports Phase 2 scleroderma trial results for FT011 at a US rheumatology meeting, showing efficacy and safety, with a pivotal study planned.

Wed 15 Nov 2023 6 entries
Fund close $6.8m

Pioneering VC fund Uniseed doubles its backers as five universities, including Monash, UTS and Macquarie, chip in

Uniseed adds Monash and a four-university NSW collaboration, lifting its third fund by $6.75 million to $56.75 million; the article recalls past portfolio sales to Novartis, Shire and Schneider Electric.

Seed $1.3m

Refilled wants to save 100 million plastic bottles from the landfill

Sydney startup Refilled has raised a A$1.3 million seed round, with Melt Ventures leading and Envato's Ta'eed brothers among backers, to scale refill stations that cut single-use plastic; Google is already a customer.

Also Startup Daily·SmartCompany·Forbes Australia

Tue 14 Nov 2023 3 entries
Mon 13 Nov 2023 3 entries
Sun 12 Nov 2023 2 entries
Funding announcement

Best of the week — the five most popular stories among readers, November 6 – 10, 2023

Weekly roundup of the five most-read stories: Tritium shifting charger production to Tennessee, Carbon Revolution's NASDAQ listing, defence grants for manufacturers, a bushfire-resistant paint hitting shelves, and Cobram Estate Olives' 25-year growth.

Fri 10 Nov 2023 1 entry
Showing 3701–3750 of 9762 ·